Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Variants inPPP2R2BandIGF2BP3are associated with higher tau deposition
Ramanan, Vijay K. , Wang, Xuewei , Przybelski, Scott A. , Raghavan, Sheelakumari , Batzler, Anthony , Kosel, Matthew , Hohman, Timothy J. , Graff‐Radford, Jonathan , Lowe, Val J. , Petersen, Ronald C. , Ross, Owen A. , Vemuri, Prashanthi , Graff-Radford, Jonathan , Mielke, Michelle M , Seto, Mabel , Vemuri, Prashanthi , Ross, Owen A , Ramanan, Vijay K , Heckman, Michael G. , Knopman, David S. , Mielke, Michelle M. , Jack, Clifford R.

Mayo Clinic

Brain Communications | September 26, 2020 | Volume: 2 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcaa159 | PMID 33426524 Get It

AbstractTau deposition is a key biological feature of Alzheimer’s disease that is closely related to cognitive impairment. However, it remains poorly understood why certain individuals may be more susceptible to tau deposition while others are more resistant. The recent availability of in vivo assessment of tau burden through positron emission tomography provides an opportunity to test the hypothesis that common genetic variants may influence tau deposition. We performed a genome-wide association study of tau-positron emission tomography on a sample of 754 individuals over age 50 (mean age 72.4 years, 54.6% men, 87.6% cognitively unimpaired) from the population-based Mayo Clinic Study of Aging. Linear regression was performed to test nucleotide polymorphism associations with AV-1451 (18F-flortaucipir) tau-positron emission tomography burden in an Alzheimer’s-signature composite region of interest, using an additive genetic model and covarying for age, sex and genetic principal components. Genome-wide significant associations with higher tau were identified for rs76752255 (P = 9.91 × 10−9, β = 0.20) in the tau phosphorylation regulatory gene PPP2R2B (protein phosphatase 2 regulatory subunit B) and for rs117402302 (P = 4.00 × 10−8, β = 0.19) near IGF2BP3 (insulin-like growth factor 2 mRNA-binding protein 3). The PPP2R2B association remained genome-wide significant after additionally covarying for global amyloid burden and cerebrovascular disease risk, while the IGF2BP3 association was partially attenuated after accounting for amyloid load. In addition to these discoveries, three single nucleotide polymorphisms within MAPT (microtubule-associated protein tau) displayed nominal associations with tau-positron emission tomography burden, and the association of the APOE (apolipoprotein E) ɛ4 allele with tau-positron emission tomography was marginally nonsignificant (P = 0.06, β = 0.07). No associations with tau-positron emission tomography burden were identified for other single nucleotide polymorphisms associated with Alzheimer’s disease clinical diagnosis in prior large case–control studies. Our findings nominate PPP2R2B and IGF2BP3 as novel potential influences on tau pathology which warrant further functional characterization. Our data are also supportive of previous literature on the associations of MAPT genetic variation with tau, and more broadly supports the inference that tau accumulation may have a genetic architecture distinct from known Alzheimer’s susceptibility genes, which may have implications for improved risk stratification and therapeutic targeting.
Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary Syndrome
Pemmasani, Gayatri , Elgendy, Islam Y. , Mamas, Mamas A. , Leighton, Jonathan A. , Aronow, Wilbert S. , Tremaine, William J., Elgendy, Islam Y , Mamas, Mamas

Mayo Clinic

Inflammatory Bowel Diseases | September 26, 2020 | Volume: 27 | Issue: 7 | Pages: 1017-1025

10.1093/ibd/izaa237 | PMID 32978941 Get It

Abstract Background Inflammatory bowel disease (IBD) is associated with an increased acute coronary syndrome (ACS) risk. Data are limited regarding the epidemiology and outcomes of ACS in patients with IBD. Methods A retrospective cohort analysis of patients with IBD admitted for ACS in the U.S. Healthcare Cost and Utilization Project National Inpatient Sample for 2005 to 2015 was conducted. We analyzed trends in IBD-ACS admissions and mortality, differences in risk profiles, management strategies, and in-hospital mortality between IBD-ACS and non-IBD ACS and between ulcerative colitis (UC) and Crohn disease (CD). Results We studied 6,872,415 non-IBD ACS and 24,220 IBD-ACS hospitalizations (53% with CD). During the study period, the number of hospitalizations for IBD-ACS increased, particularly those related to CD. Compared with non-IBD ACS, patients with IBD-ACS had a lower prevalence of cardiovascular risk factors and similar rates of coronary angiography and revascularization. The in-hospital mortality rate was lower with IBD-ACS (3.9%) compared with non-IBD ACS (5.3%; odds ratio, 0.81; 95% confidence interval, 0.69-0.96; P = 0.011) and was stable between 2005 and 2015. Risk factors, ACS management strategies, and mortality were similar between CD and UC. Coagulopathy, weight loss, and gastrointestinal bleeding were more frequent in IBD-ACS and were strong independent predictors of mortality. Conclusions Hospitalizations for ACS in patients with IBD increased in recent years but death rates were stable. The ACS-related risk profiles and mortality were modestly favorable with IBD-ACS than with non-IBD ACS and were similar between CD and UC. Complications more frequently associated with IBD were strongly associated with mortality. These findings indicate that aggressive management of IBD and ACS comorbidities is required to improve outcomes.
Three-Dimensional-Printed Liver Model Helps Learners Identify Hepatic Subsegments: A Randomized-Controlled Cross-Over Trial
Chedid, Victor , Kamath, A. , Knudsen, John M. , Frimannsdottir, Katrin R., Yost, Kathleen J. , Geske, Jennifer R. , Taner, Timuçin , Matsumoto, Jane M., Kamath, Patrick S. , Chedid, Victor G , Kamath, Amika A, M Knudsen, John, Frimannsdottir, Katrin, R Geske, Jennifer, Geske, Jennifer , Morris, Jonathan M.

Mayo Clinic

American Journal of Gastroenterology | September 25, 2020 | Volume: 115 | Issue: 11 | Pages: 1906-1910

10.14309/ajg.0000000000000958 | PMID 33156110 Get It

INTRODUCTION: The purpose of this study was to find out whether 3-dimensional (3D)–printed models improved the learners' ability to identify liver segments. METHODS: A total of 116 physicians from 3 disciplines were tested in a cross-over trial at baseline and after teaching with 3D models and 2-dimensional (2D) images. Adjusted multilevel-mixed models were used to compare scores at baseline and after 3D and 2D. RESULTS: Accuracy in identifying hepatic segments was higher with 3D first than 2D (77% vs 69%; P = 0.05) and not significantly improved by a combination of 3D and 2D. Increased confidence in segment identification was highest in trainees after 3D ( P = 0.04). DISCUSSION: 3D-printed models facilitate learning hepatic segmental anatomy.
Network Localization of Alien Limb in Patients with Corticobasal Syndrome
Tetreault, Aaron M., Phan, Tony X. , Petersen, Kalen J. , Claassen, Daniel O. , Neth, Byran J. , Graff‐Radford, Jonathan , Albrecht, Franziska , Fließbach, Klaus , Schneider, Anja , Synofzik, Matthis , Diehl‐Schmid, Janine , Otto, Markus , Darby, R. Ryan , Initiative, for the 4 Repeat Tau Neuroimaging, Neth, Bryan J. , Darby, Richard Ryan , Synofzik, Matthis , Otto, Markus , Claassen, Daniel , Schroeter, Matthias L , Initiative, for the 4 Repeat Tau Neuroimaging

Mayo Clinic

Annals of Neurology | September 24, 2020 | Volume: 88 | Issue: 6 | Pages: 1118-1131

10.1002/ana.25901 | PMID 32935385 Get It

ObjectivePerirolandic atrophy occurs in corticobasal syndrome (CBS) but is not specific versus progressive supranuclear palsy (PSP). There is heterogeneity in the locations of atrophy outside the perirolandic cortex and it remains unknown why atrophy in different locations would cause the same CBS‐specific symptoms. In prior work, we used a wiring diagram of the brain called the human connectome to localize lesion‐induced disorders to symptom‐specific brain networks. Here, we use a similar technique termed “atrophy network mapping” to localize single‐subject atrophy maps to symptom‐specific brain networks.MethodsSingle‐subject atrophy maps were generated by comparing cortical thickness in patients with CBS versus controls. Next, we performed seed‐based functional connectivity using a large normative connectome to determine brain regions functionally connected to each patient's atrophied locations.ResultsPatients with CBS had perirolandic atrophy versus controls at the group level, but locations of atrophy in CBS were heterogeneous outside of the perirolandic cortex at the single‐subject level (mean spatial correlation = 0.04). In contrast, atrophy occurred in locations functionally connected to the perirolandic cortex in all patients with CBS (spatial correlation = 0.66). Compared with PSP, patients with CBS had atrophy connected to a network of higher‐order sensorimotor regions beyond perirolandic cortex, matching a CBS atrophy network from a recent meta‐analysis. Finally, atrophy network mapping identified a symptom‐specific network for alien limb, matching a lesion‐induced alien limb network and a network associated with agency in healthy subjects.InterpretationWe identified a syndrome‐specific network for CBS and symptom‐specific network for alien limb using single‐subject atrophy maps and the human connectome. ANN NEUROL 2020;88:1118–1131
How to Restart the Interventional Activity in the COVID‐19 Era: The Experience of a Private Pain Unit in Spain
Abejón, David , Monzón, Eva , Deer, Timothy R. , Hagedorn, Jonathan M. , Araujo, Ricardo , Abad, Cristina , Rios, Alberto , Zamora, Alejandro , Monzón, Eva M , Deer, Tim , Hagedorn, Jonathan M , Araujo, Ricardo , Vallejo, Ricardo

Mayo Clinic

Pain Practice | September 24, 2020 | Volume: 20 | Issue: 8 | Pages: 820-828

10.1111/papr.12951 | PMID 32969188 Get It

AbstractIntroductionThe situation generated in the health system by the COVID‐19 pandemic has provoked a crisis involving the necessity to cancel non‐urgent and oncologic activity in the operating room and in day‐to‐day practice. As the situation continues, the need to reinstate attention for patients with chronic pain grows. The restoration of this activity has to begin with on‐site appointments and possible surgical procedures. On‐site clinical activity has to guarantee the safety of patients and health workers.ObjectivesThe objective of this review was to evaluate how to manage activity in pain units, considering the scenario generated by the pandemic and the implications of chronic pain on the immune system and proposed pharmacological and interventional therapies.MethodsBesides the established general recommendations (physical distance, surgical masks, gloves, etc.), we established specific recommendations that will allow patient treatment and relieve the disruption of the immune response. It is important to highlight the use of opioids with the least influence in the immune system. Further, individualized corticoid use, risk assessment, reduced immune suppression, and dose adjustment should take patient needs into account. In this scenario, we highlight the use of radiofrequency and neuromodulation therapies, techniques that do not interfere with the immune response.ConclusionsWe describe procedures to implement these recommendations for individual clinical situations, the therapeutic possibilities and safety guidelines for each center, and government recommendations during the COVID‐19 pandemic.
Cardiac Abnormalities Seen in Pediatric Patients During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: An International Experience
Clark, Bradley C. , Sánchez-de-Toledo, Joan , Bautista-Rodríguez, Carles , Choueiter, Nadine , Lara, Diego, Kang, Hechaan, Fraisse, Alain , César, Sergi , Shaikh, Abdul Sattar , Escobar‐Diaz, Maria C. , Randanne, Paula C. , Kleinmahon, Jake , Lamour, Jacqueline M. , Johnson, Jonathan N. , Chowdhury, Devyani , Mohsin, Shazia , Hsu, Daphne T. , Aslam, Nadeem, Sarquella-Brugada, Georgia

Mayo Clinic

Journal of the American Heart Association | September 22, 2020 | Volume: 9 | Issue: 21 | Pages: No page available

10.1161/jaha.120.018007 | PMID 32957826 Get It

Background During the severe acute respiratory syndrome Coronavirus 2 pandemic, there has been an increase in hyperinflammatory presentation in previously healthy children with a variety of cardiac manifestations. Our objective is to describe the cardiac manifestations found in an international cohort of 55 pediatric cases with multi‐system inflammatory syndrome during the severe acute respiratory syndrome Coronavirus 2 pandemic. Methods and Results We reviewed data on previously healthy pediatric patients (≤18 years) with structurally normal hearts who presented at hospitals in the United States, United Kingdom, Spain, and Pakistan with multi‐system inflammatory syndrome in children and had consultation with a pediatric cardiologist. Data collected included demographics, clinical presentation, laboratory values, electrocardiographic abnormalities, echocardiographic findings, and initial therapies. A total of 55 patients presented with multi‐system inflammatory syndrome in children. Thirty‐five patients (64%) had evidence of decreased left ventricular function, 17 (31%) had valvulitis, 12 (22%) with pericardial effusion, and 11 (20%) with coronary abnormalities. Twenty‐seven (49%) required intensive care unit admission and 24 (44%) had evidence of shock. Eleven patients (20%) fulfilled complete Kawasaki disease criteria and had lower NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide), D‐dimer, and ferritin levels compared with those who did not fulfill criteria. Electrophysiologic abnormalities occurred in 6 patients and included complete atrioventricular block, transient atrioventricular block, and ventricular tachycardia. Conclusions To our knowledge, we describe the first international cohort of pediatric patients with multi‐system inflammatory syndrome in children during the severe acute respiratory syndrome Coronavirus 2 pandemic with a range of cardiac manifestations. This article brings awareness and alertness to the global medical community to recognize these children during the pandemic and understand the need for early cardiology evaluation and follow‐up.
Characteristics and outcomes of patients with peripheral artery disease undergoing endovascular revascularization: A community hospital perspective
Gharacholou, S. Michael , Li, Zhuo , Uy, Jonathan J, Eckstein, Lee H, Flock, Carolyn R., Senger, Joshua L, Gutiérrez, Jorge F Trejo, Chapman, Scott C., Michael Gharacholou, S

Mayo Clinic

Vascular | September 21, 2020 | Volume: 29 | Issue: 3 | Pages: 372-379

10.1177/1708538120958858 | PMID 32951559 Get It

Background There are limited data on outcomes for patients with peripheral artery disease undergoing endovascular revascularization by multi-disciplinary teams in a community hospital setting. Methods From January 2015 through December 2015, we assembled a multi-disciplinary program comprised of cardiologists, surgeons, radiologists, nurses, and administrative staff for managing patients with peripheral artery disease undergoing endovascular revascularization. Demographic, procedural, and outcomes data were collected with use of a template from the Society for Vascular Surgery Vascular Quality Initiative database. We compared characteristics and outcomes of patients with intermittent claudication and critical limb ischemia. We used Kaplan–Meier methods to estimate the rate of overall survival and freedom from rehospitalization between groups. Results After excluding patients with acute limb ischemia ( n = 5), peripheral intervention to the upper extremity ( n = 6), or abdominal aorta ( n = 11), there were 82 patients in the study cohort; 45 had intermittent claudication and 37 had critical limb ischemia. Baseline and procedural characteristics were similar between groups, although critical limb ischemia patients were more likely to have hyperlipidemia (75.7% vs. 53.3%, P = .42). Procedural success was achieved in 91.3% of cases. Actionable access site bleeding occurred in 2.4% of patients. High rates of aspirin (91.5%) and statin (87.8%) were noted at discharge. After two years of post endovascular revascularization, survival was 57.5% for critical limb ischemia patients and 94.4% for intermittent claudication patients ( P < .001). Freedom from rehospitalization was 32.7% for critical limb ischemia patients and 83.5% for intermittent claudication patients ( P < .001). Conclusions We found that favorable outcomes may be achieved with a multi-disciplinary peripheral artery disease program at community hospitals. The incorporation of quality improvement practices may further help to develop standardized and regionalized approaches to care delivery for patients with peripheral artery disease.
Noncompetitive Allosteric Antagonism of Death Receptor 5 by a Synthetic Affibody Ligand
Szymonski, Sophia, Sachs, Jonathan N. , Hackel, Benjamin J. , Sachs, Jonathan N , Hackel, Benjamin J , Vunnam, Nagamani , Hirsova, Petra , Gores, Gregory J.

Mayo Clinic

Biochemistry | September 17, 2020 | Volume: 59 | Issue: 40 | Pages: 3856-3868

10.1021/acs.biochem.0c00529 | PMID 32941010 Get It

Radiological Prevalence of Popliteal Artery Entrapment in Individuals With Anterior Leg Compartment Chronic Exertional Compartment Syndrome
Johnson, Shelby E. , Amrami, Kimberly K. , Jelsing, Elena J., Finnoff, Jonathan T.

Mayo Clinic

Clinical Journal of Sport Medicine | September 17, 2020 | Volume: 32 | Issue: 2 | Pages: e160-e164

10.1097/jsm.0000000000000885 | PMID 32941383 Get It

Objective: Determine the radiological prevalence of popliteal artery entrapment (PAE) in subjects with anterior leg compartment chronic exertional compartment syndrome (CECS). Design: Retrospective review. Setting: Tertiary care center. Patients: Of 71 patients diagnosed with anterior leg compartment CECS using an in-scanner exercise-based magnetic resonance imaging (MRI), 64 also completed Fast Imaging Employing Steady-State Acquisition (FIESTA) imaging. Interventions: Electronic health records of patients diagnosed with anterior leg compartment CECS using an in-scanner exercise-based MRI between 2009 and 2018 were reviewed. Main Outcome Measures: Demographics, symptom laterality, and results of vascular work-up. Results: Magnetic resonance imaging was positive for PAE in 33 of 64 (51.6%). Vascular evaluation was performed in 30 of 33 (90.9%). Of these 30, ankle-brachial indices (ABIs) with PAE maneuvers were performed in 29 (96.7%) and positive in 25 (86.2%). Pre-exercise and post-exercise ABIs were performed in 29 (96.7%) and abnormal in 20 (69.0%). Thirteen arterial duplex ultrasounds were performed; 10 were consistent with PAE (76.9%). An MR angiogram was performed in 8 (26.7%) and consistent with PAE in all. One computed tomography angiogram (3.3%) was completed and was normal. Overall, one or more tests were positive for PAE in all 30 with vascular evaluation. Conclusions: The radiological prevalence of PAE and anterior leg CECS was 51.6%. All subjects with vascular studies (90.9%) had one or more tests confirming radiological PAE. These findings suggest that the coexistence of PAE and CECS is common, and the PAE protocol used has a high correlation with vascular studies.
Knotless Arthroscopic Repair of Subscapularis Avulsion Fracture Using a Single Anterior Portal
Baker, Courtney E. , Barlow, Jonathan D. , Camp, Christopher L.

Mayo Clinic

Arthroscopy Techniques | September 15, 2020 | Volume: 9 | Issue: 10 | Pages: No page available

10.1016/j.eats.2020.06.004 | PMID 33134046 Get It

Abstract Proximal humerus lesser tuberosity avulsions are uncommon injuries; however, when present, they can be debilitating for patients. As such, they pose a unique clinical challenge. These fractures were traditionally treated through an open approach to the proximal humerus; however, arthroscopic techniques continue to evolve and are increasingly used for these types of injuries. We describe our minimally invasive arthroscopic technique to repair lesser tuberosity avulsions using standard arthroscopic equipment. This method is safe, efficient, and applies basic shoulder arthroscopic techniques. Technique Video video See video under supplementary data.